#BeInTheKnow: National Gay Men's HIV/AIDS Awareness Day
Noël Gordon, Human Rights Campaign; Posted Sep 27, 12:27 p.m. ET
Today marks National Gay Men's HIV/AIDS Awareness Day, an opportunity to focus our attention on the impact of HIV and AIDS on gay and bisexual men in the U.S.
Election 2016 Resources for People Living With HIV
The Center for HIV Law and Policy; Posted Sep 27, 11:31 a.m. ET
What's at stake in Election 2016 for People Living with HIV? Getting information on the issues and getting out the vote has never been more important.
Catching Fire: The Realities of the New Era in HIV Prevention and Care
Richard Wolitski, Ph.D., AIDS.gov; Posted Sep 27, 11:16 a.m. ET
"We're at the start of something new, something important, that's just starting to catch fire," Richard Wolitski, Ph.D., writes. "I can't tell you how many conversations I had with government, national and community leaders last week at USCA about what treatment as prevention and PrEP mean for our work and our lives."
First Generic Version of Dolutegravir Approved by the FDA
Polly Clayden, HIV i-Base; Posted Sep 26, 2:53 p.m. ET
Aurobindo Pharma has received U.S. FDA tentative approval for dolutegravir -- the first generic version to be approved, expected to be launched in sub-Saharan Africa in late 2016.
Everyone living with HIV has a story to tell. Find out how to share your own experiences in one or both of the series below, which feature the writings of readers like you.
Regardless of where or how it happened, the day you received your HIV-positive diagnosis was likely among the most intense days you'll ever live through. Some of TheBody.com's readers have generously shared their experiences -- to reflect on how they've changed, and so that others would know that they too can survive, and even thrive, following that fateful day. How did you get through it?
Many types of medications can save or improve lives, but they can also have unintended consequences. For some people living with HIV, taking meds can be a complicated cycle -- and for others, a Sunday stroll. Medication side effects can be mild or life altering, horrible or even pleasurable; some people living with HIV never experience any at all. It seems like everyone's got a story about side effects. What's yours?
The Role of Housing and the Black Church in HIV in America
AIDS United; Posted Sep 26, 2:16 p.m. ET
At the recent Congressional Black Caucus Foundation Annual Legislative Conference, Representatives Barbara Lee (D-CA) and Keith Ellison (D-MN) hosted a pair of panel discussions that examined the impact of affordable rental housing on the health of the black community and the role that the black church has to play in fighting AIDS.
Five Things Providers Said About PrEP at a Family Planning Conference
Sara Semelka and Pamela Tassin, AIDS Foundation of Chicago; Posted Sep 26, 1:20 p.m. ET
"Getting PrEP information in front of family planning providers could make a big difference in women's access to the HIV prevention tool," Sara Semelka and Pamela Tassin write.
Atripla 3 Days a Week for 2 Years: Pilot Switch Study Reports Undetectable Viral Load With Better Bone, Kidneys and Sleep
Simon Collins, HIV i-Base; Posted Sep 26, 1:16 p.m. ET
A small pilot study that switched people with undetectable viral load to reduced dosing for the Atripla reported no viral load rebounds with follow-up results out to two years.
Neurological Side Effects With Integrase Inhibitors Cause Discontinuations in Clinical Practice
Simon Collins, HIV i-Base; Posted Sep 26, 1:16 p.m. ET
An analysis from use of integrase inhibitors in clinical practice reported significantly higher rates of discontinuations related to side effects than seen in clinical studies and includes neurologial complications with dolutegravir.
My Health Tracker can help you organize your HIV treatment information privately and securely in one place. This way, you can take better charge over your health, and you and your doctor can have even more productive conversations about your treatment.
Registration takes only a couple of minutes, requires no personal info, and you'll be able to pick up where you left off at any time.
This Week in HIV Research: Body Mass Index Predicts Diabetes After Year of HIV Treatment, and Streamlining Screening for Neurological Disorders
Barbara Jungwirth, TheBodyPRO.com; Posted Sep 23, 7:08 p.m. ET
This week, a study finds that body mass index is associated with type-2 diabetes risk after 12 months of treatment. Another study seeks to streamline testing for HIV-associated neurocognitive disorders (HAND).
My Attitude Adjustment About Sex, Gonorrhea and Advocacy
Mark S. King, MyFabulousDisease.com; Posted Sep 23, 6:06 p.m. ET
"Amidst the happy haze of good news about the efficacy of PrEP in preventing new HIV infections and the growing consensus that people living with HIV who are undetectable are not infectious, there is troubling news from the CDC in two new reports about the golden oldies of sexually transmitted infections: rates of syphilis are on the rise and antibiotics to treat gonorrhea may be nearing the end of their usefulness," Mark S. King writes.
Moralism, Plentiful in HIV Prevention, Is the Fuel of Stigma
Abdul-Aliy A Muhammad, TheBody.com; Posted Sep 23, 5:45 p.m. ET
Moralism is bound to rear its ugly head on the battleground of HIV prevention, relying on the concept that those most vulnerable are not in a position to save themselves and do-good outsiders play the most important role in relieving them of oppression, says Abdul-Aliy A Muhammad.
11 Sexy Campaigns That Spread the Word -- and the Love -- on PrEP
Olivia G. Ford, TheBody.com; Posted Sep 23, 4:41 p.m. ET
Take a stroll through some of the top campaigns keeping HIV prevention sexy and real in the PrEP era.
>> Browse Older Featured Stories